Please ensure Javascript is enabled for purposes of website accessibility

Instant Analysis: Accenture Trounces Q2 Estimates

By Eric Volkman – Apr 1, 2016 at 3:07PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company blows past analyst projections in an excellent quarter.

What happened?
Shares of business consultancy and services provider Accenture (ACN -0.94%) are trading up slightly in the wake of a very encouraging earnings report. The company reported its fiscal Q2 2016 results, which revealed it brought in revenue of just under $8 billion, and netted an adjusted profit of $905 million ($1.34 per diluted share). That top line figure was 6% higher on a year-over-year basis, while the per-share bottom line result was a whopping 24% improvement.


Both line items were substantially above the average analyst estimates; these anticipated $7.7 billion in revenue, and adjusted EPS of $1.18.

The better-than-expected results should filter down to fiscal 2016's bottom line. Accenture raised its guidance for the full year -- it now believes it will post an adjusted EPS of $5.21 to $5.32. It previously forecast a range of $5.09 to $5.24.

Does it matter?
Accenture is a company in transition -- it wants to turn its business toward online and cloud services. Unlike many other enterprises in a similar situation, though, you'd never know it from the financials. The company continues to add to its considerable top line, netting out substantial profits while doing so. It says that its pivot toward higher-growth segments fueled the increases; going forward, this should help drive the anticipated higher profitability.

Being involved in lucrative projects also helps. Accenture is doing a lot of work for the government's once-janky website, which according to many has vastly improved since the early days of Obamacare. During the quarter, the company's health and public services segment saw a 12% year-over-year rise in sales.

Accenture's Q2 results should encourage investors that the company is on the right path with its transition, and more than holding its own while it gets there. We should keep in mind, however, that there is plenty of competition, particularly in Accenture's traditional wheelhouse of business consulting.

Eric Volkman has no position in any stocks mentioned. The Motley Fool recommends Accenture. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Accenture plc Stock Quote
Accenture plc
$257.54 (-0.94%) $-2.44

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.